PPLPHARMA
Piramal Pharma Limited
Pharmaceuticals
Share price
₹214
Market cap
₹28,431 Cr
1Y return
▲ 11%
A pharmaceutical company operating across three major segments: contract development and manufacturing organisations, complex hospital generics for critical care, and consumer healthcare products. Established through the acquisition of Nicholas Laboratories in 1988, the company has expanded via strategic mergers and acquisitions alongside organic growth initiatives. It serves healthcare providers and consumers across India through its diversified business operations and specialized pharmaceutical solutions.
Investors holding Piramal Pharma Limited
2.00%
Latest move
Canara Robeco Mutual FundExited
Canara Robeco Mutual Fund, which last reported a 1.0 percent stake in Piramal Pharma Limited, is no longer on the list of disclosed shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.
Sign in to read more
Whales made 2 more moves in Piramal Pharma Limited
Sign in to see who is buying and selling.
Sign in to find out